NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/27/2024
Back to search
Official data from USPTO
MYADMIA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
08/27/2024
Trademark type
Word
Nice classes
5
Filing date
09/12/2022
Registration date
08/27/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/27/2024
Last transaction
08/27/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
99
Owner location
Glattpark-Opfikon, CH
Examiner
YARD, JOHN
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Takeda Pharmaceuticals International AG
Representatives
Karl M. Zielaznicki, Esq. TROUTMAN PEPPER HAMILTON SANDERS LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationspreparations for enzyme replacement therapy for thrombotic disorders; Pharmaceutical preparations for treatment of thrombotic disorders by means of enzyme replacement therapy
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/27/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/11/2024
PUBO
PUBLISHED FOR OPPOSITION
06/11/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/22/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/07/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/07/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/06/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/06/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/01/2024
GNRT
NON-FINAL ACTION E-MAILED
05/01/2024
CNRT
NON-FINAL ACTION WRITTEN
05/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/27/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/27/2024
ALIE
ASSIGNED TO LIE
03/27/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/08/2023
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
09/14/2023
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
09/14/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/24/2023
GNRT
NON-FINAL ACTION E-MAILED
06/24/2023
CNRT
NON-FINAL ACTION WRITTEN
06/24/2023
DOCK
ASSIGNED TO EXAMINER
06/24/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/29/2022
NWAP
NEW APPLICATION ENTERED
09/15/2022
Continuous trademark protection
Get notified about every new filing that threatens MYADMIA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.